SIMPEX Bisacodyl laxative

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
SIMPEX Bisacodyl laxative
Generic name
BISACODYL
Manufacturer
Simpex Pharma Pvt. Ltd
Product type
HUMAN OTC DRUG
SPL set ID
5114ed64-4fec-401b-8a91-8df3e42b10b1
SPL ID
0b586450-2c14-70e7-e063-6394a90a5f33
Version
7
Effective date
2023-11-29
Source export date
2026-09-28
Source partition
11
Source file
https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/aa96b5a2be6b394393acd0090f6948bdf99e0e8e00666f81608929c8fa83db77/drug-label-0011-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:15:09
Harmonized routes table
Harmonized routes
ORAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do not use if you can not swallow without chewing. ask a doctor before use if you have stomach pain, nausea or vomiting a sudden change in bowel habits that lasts more than weeks When using this product do not chew or crush tablet (s) do not use within 1 hour after taking an antacid or milk you may have stomach discomfort, faintness or cramps Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use a laxative. these could be signs of a serious condition. you need to use a laxative for more than 1 week if pregnant or breast-feeding, ask a health professional before use. keep out of reach of children. In case or overdose, get medical help orcontact a poison control center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.